Balentine LLC’s ICU Medical ICUI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-24
Closed -$4K 488
2020
Q2
$4K Hold
24
﹤0.01% 765
2020
Q1
$5K Hold
24
﹤0.01% 478
2019
Q4
$4K Hold
24
﹤0.01% 483
2019
Q3
$4K Sell
24
-8
-25% -$1.59K ﹤0.01% 572
2019
Q2
$8K Buy
32
+8
+33% +$1.85K ﹤0.01% 362
2019
Q1
$6K Hold
24
﹤0.01% 373
2018
Q4
$6K Hold
24
﹤0.01% 333
2018
Q3
$7K Buy
+24
New +$7.03K ﹤0.01% 236
2018
Q1
Sell
-145
Closed -$31K 266
2017
Q4
$31K Sell
145
-10
-6% -$2.02K ﹤0.01% 332
2017
Q3
$29K Sell
155
-25
-14% -$4.36K ﹤0.01% 340
2017
Q2
$31K Sell
180
-40
-18% -$6.42K ﹤0.01% 308
2017
Q1
$34K Buy
220
+30
+16% +$4.38K ﹤0.01% 278
2016
Q4
$28K Buy
190
+40
+27% +$5.79K ﹤0.01% 272
2016
Q3
$19K Hold
150
﹤0.01% 286
2016
Q2
$17K Hold
150
﹤0.01% 267
2016
Q1
$16K Buy
150
+10
+7% +$956 ﹤0.01% 202
2015
Q4
$16K Hold
140
﹤0.01% 275
2015
Q3
$15K Sell
140
-20
-13% -$2.14K ﹤0.01% 306
2015
Q2
$15K Sell
160
-80
-33% -$7.48K ﹤0.01% 283
2015
Q1
$22K Buy
+240
New +$21K ﹤0.01% 230

Other funds holding ICUI

Balentine LLC's ICUI Position: Q3 2020 in Review

Balentine LLC sold out of ICU Medical (ICUI) in Q3 2020, closing a stake of 24 shares — an estimated $4K sold.

Balentine LLC first reported a position in ICUI in Q1 2015 and held it in 20 quarters. The position peaked at $34K in Q1 2017. 283 funds tracked by Wall St. Rank hold ICUI as of Q3 2020.

  • Balentine LLC reported no remaining ICU Medical position as of Q3 2020 after selling out during the quarter.
  • Balentine LLC sold 24 ICU Medical shares in Q3 2020, an estimated $4K.
  • Balentine LLC first reported a position in ICU Medical in Q1 2015 and held it in 20 quarters.
  • Balentine LLC's ICU Medical position peaked at $34K in Q1 2017.
  • 283 funds tracked by Wall St. Rank held ICU Medical as of Q3 2020.

Based on Balentine LLC's 13F filing for Q3 2020, filed 2 Nov 2020.